Toward the Pathway of S. aureus WTA Biosynthesis  by Xia, Guoqing & Peschel, Andreas
Chemistry & Biology
PreviewsToward the Pathway of S. aureusWTA Biosynthesis
Guoqing Xia1 and Andreas Peschel1,*
1Cellular and Molecular Microbiology Section, Medical Microbiology and Hygiene Department, University of Tu¨bingen,
Elfriede-Aulhorn-Strasse 6, 72076 Tu¨bingen, Germany
*Correspondence: andreas.peschel@uni-tuebingen.de
DOI 10.1016/j.chembiol.2008.02.005
Wall teichoic acid (WTA) contributes profoundly to the virulence of Staphylococcus aureus. The successful
in vitro reconstitution of poly-ribitolphosphate WTA biosynthesis using recombinant enzymes sheds new
light on WTA enzymology and paves the way for developing new antibiotics that target WTA biosynthesis,
as discussed in Brown et al. in a recent issue of Chemistry & Biology.In contrast to Gram-negative bacteria,
which have an outer membrane, Gram-
positive bacteria are less well protected
from small harmful molecules that can
easily penetrate trough the peptidoglycan
cell wall. This seems to be a major reason
for incorporation of additional cell wall
glycopolymers (CWG) into the envelopes
of most Gram-positive bacterial species
(Weidenmaier and Peschel, 2008). Be-
cause of their surface-exposed nature,
CWG represent important targets for
anti-infective vaccines, antibiotics, and
diagnostics. The best-studied CWG are
probably the teichoic acids, which are
distinguished from other types of CWG
by the presence of phosphate in the
polymer backbone. The peptidoglycan-
attached teichoic acids (WTA) are highly
variable in structure and occur as rather
simple glycerolphosphate (GroP) poly-
mers, e.g., in Bacillus subtilis 168, or with
rather complex combinations of building
blocks (Weidenmaier and Peschel, 2008).
WTA composed of ribitolphosphate
(RboP) in addition to GroP building blocks
is produced by important human patho-
gens such as Staphylococcus aureus,
Staphylococcus saprophyticus, and
Listeria monocytogenes. WTA has been
shown to be dispensable for viability of
S. aureus but to contribute profoundly to
S. aureus host-cell binding, immune eva-
sion, and virulence (Weidenmaier et al.,
2004; Peschel et al., 1999). Therefore,
WTA biosynthesis represents an interest-
ing target for new antibiotics against noto-
riously antibiotic resistant bacteria such
as S. aureus.
WTA is covalently liked to peptidogly-
can through a linkage unit that usually
consists of a GlcNAc-ManNAc disaccha-
ride. The S. aureusWTA polymer contains
2 or 3 units of GroP followed by 40 unitsof RboP, which are further modified with
GlcNAc and D-alanine residue (Weiden-
maier and Peschel, 2008) (Figure 1A).
In vitro WTA polymerase studies from the
1960s demonstrated the involvement of
CDP-glycerol and CDP-ribitol precursors
in WTA polymerization. Subsequently,
several WTA biosynthetic genes were
identified in B. subtilis 168 and shown to
be clustered (tagABDEFGH) (Pooley and
Karamata, 1994) or encoded separately
(tagO) (Soldo et al., 2002). TagO was sug-
gested to initiate WTA biosynthesis by
transferring GlcNAc–phosphate to the
lipid carrier undecaprenylphosphate. Us-
ing recombinant B. subtilis enzymes, the
functions of TagA in ManNAc incorpora-
tion into the linkage unit, TagD in CDP-
glycerol generation, TagB in addition to
the first GroP, and TagF in GroP polymer-
ization could be established (Ginsberg
et al., 2006; Park et al., 1993; Bhavsar
andBrown, 2006). Comparative genomics
revealed a similar organization of several
WTA biosynthetic genes in S. aureus
(Qian et al., 2006; Figure 1A) and enabled
the generation of aS. aureus tagOmutant,
which was devoid of WTA, thereby dem-
onstrating that WTA is dispensable for
viability but required for S. aureus coloni-
zation and infection (Weidenmaier et al.,
2004). However, the rather complex com-
positionofS. aureusWTAwas reflectedby
the presence of an additional gene cluster
(tarFIJL), which had previously also been
identified in a B. subtilis strain (W23) pro-
ducing poly-RboPWTA.While TarIJ could
be shown to be responsible forCDP-ribitol
generation (Pereira and Brown, 2004), it
remained unclear which genes were re-
sponsible for RboP polymerization. This
question was further complicated by the
obvious duplication of the tarIJL genes
(Figure 1A). Corresponding biochemicalChemistry & Biology 15, February 20studies proved to be very challenging
because of the lipophilic nature of the
lipid carrier-bound substrates. One of
the major advancements in the field was
the recent chemoenzymatic synthesis of
a lipid carrier analog with a farnesyl chain,
which was less hydrophobic than the
C55 undecaprenyl group. This enabled the
in vitro reconstitution of early steps in
B. subtilis WTA biosynthesis (Ginsberg
et al., 2006).
In the January 2008 issue of Chemistry
& Biology, Brown et al. describe the
in vitro reconstitution of four main intra-
cellular steps ofS. aureusWTAbiosynthe-
sis downstream of TagO using purified
recombinant enzymes (Figure 1B; Brown
et al., 2008). Their data confirm that
TagA and TagB mediate the same steps
in S. aureus WTA biosynthesis as in B.
subtilis 168. Most importantly, they dem-
onstrate that TarF is responsible for add-
ing a second GroP to the linkage unit
and that TarL2 represents the RboP poly-
merase. Their data further demonstrate
that S. aureus WTA contains only two
GroP units instead of three, as previously
reported, and that no additional RboP
primase is required. Another important
aspect of the study is the finding that
only one of the two tarL genes (tarL2)
of the duplicated tarIJL gene cluster is
active, while the other one is either not
expressed or defective. This result is in
accord with the previously observed
dispensability of tarL1 (Bae et al., 2004).
Most of the enzymes involved in the
early steps of WTA biosynthesis are con-
served and organized in similar gene clus-
ters in many Gram-positive genomes. Ac-
cordingly, they have been given the same
names (tagO, tagAHGBXD) in many publi-
cations and in genome annotations. In
some recent publications, among them08 ª2008 Elsevier Ltd All rights reserved 95
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named as ‘‘tarO.’’ in bacteria incorporat-
ing ribitol into their WTA. In order to better
convey relevant information and reduce
confusion, we suggest keeping the origi-
nal ‘‘tag’’ names for the initial highly con-
served steps and using ‘‘tar’’ only for the
late tarFIJL genes, which are specific for
poly-RboP WTA and are often located in
a separate gene cluster.
While most of the intracellular WTA bio-
synthetic steps seem to have been eluci-
dated by now, understanding of the last
steps is still in its infancy and represents
a challenge for future studies. Evidence
for a role of TagGH in WTA translocation
to the outer leaflet of the cytoplasmic
membrane is only very indirect (Lazarevic
and Karamata, 1995). Moreover, the en-
zyme eventually transferring WTA to pep-
tidoglycan precursors is still unknown.
While critical steps of WTA biosynthesis
have been reconstituted in vitro, it re-
mains a challenge to employ these assays
for high-throughput inhibitor screening
approaches. Of note, the quest for inhibi-
tors of the D-alanylation pathway has
recently yielded very promising results
(Escaich et al., 2007). In addition to the
biochemical issues, important questions
remain concerning the roles of CWG
such as WTA and their enormous struc-
tural variability in bacterial physiology
and host interaction.
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Figure 1. Genes and Enzymes Involved in S. aureus WTA Biosynthesis
(A) WTA gene clusters ofS. aureusNTCT8325 (left) and schematicWTA structure (right) are shown. The tag
and tar genes are involved in WTA backbone biosynthesis, while the dlt operon is responsible for teichoic
acid D-alanylation. The tagA, tagB, tarF, and tarL2 genes and WTA building blocks transferred by the cor-
responding enzymes as characterized in the reference paper (Brown et al., 2008) are marked in blue, yel-
low, red, and green, respectively.
(B) Pathway of poly-RboP WTA biosynthesis in S. aureus. The unknown enzyme transferring the polymer
to peptidoglycan is indicated by a question mark. C55-P, undecaprenyl phosphate; GlcNAc-P, N-acetyl-
glucosaminephosphate; ManNAc, N-acetyl-mannosamine; Rib-P, ribulose-5-phosphate; Gro-P, glycer-
olphosphate; RboP, ribitolphosphate.96 Chemistry & Biology 15, February 2008 ª2008 Elsevier Ltd All rights reserved
